These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8877317)

  • 1. Application of the method of spectral-statistical analysis EMG for evaluating the influence of medication on the treatment of Parkinson's disease.
    Khutorskaya OY; Fjodorova NV
    Electromyogr Clin Neurophysiol; 1996; 36(5):265-8. PubMed ID: 8877317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
    Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
    Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action tremor and weakness in Parkinson's disease: a study of the elbow extensors.
    Brown P; Corcos DM; Rothwell JC
    Mov Disord; 1998 Jan; 13(1):56-60. PubMed ID: 9452327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMG and MMG activities of agonist and antagonist muscles in Parkinson's disease patients during absolute submaximal load holding.
    Marusiak J; Jaskólska A; Kisiel-Sajewicz K; Yue GH; Jaskólski A
    J Electromyogr Kinesiol; 2009 Oct; 19(5):903-14. PubMed ID: 18456512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application EMGs spectral analysis method for the objective diagnosis of different clinical forms of Parkinson's disease.
    Andreeva YeA ; Khutorskaya OYe
    Electromyogr Clin Neurophysiol; 1996; 36(3):187-92. PubMed ID: 8737941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease.
    Vaillancourt DE; Prodoehl J; Verhagen Metman L; Bakay RA; Corcos DM
    Brain; 2004 Mar; 127(Pt 3):491-504. PubMed ID: 14662520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of medication in Parkinson's disease: a wavelet analysis of EMG signals.
    Strambi SK; Rossi B; De Michele G; Sello S
    Med Eng Phys; 2004 May; 26(4):279-90. PubMed ID: 15121053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuronal activities in the ventrolateral thalamus and basal ganglia in relation to Parkinson's disease].
    Wang J; Zhuang P; Li YJ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1021-6. PubMed ID: 16784702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicophysiological study of tremor in Parkinson's disease: quantitative tremor-based assessment of motor count using actigraphy].
    Mochio S; Oka H; Katayama K; Sato H
    Nihon Rinsho; 1997 Jan; 55(1):158-62. PubMed ID: 9014442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Depressive symptoms and motor condition in Parkinson's disease patients].
    Stella F; Bucken-Gobbi LT; Gobbi S; Sant'Ana-Simões C
    Rev Neurol; 2007 Nov 16-30; 45(10):594-8. PubMed ID: 18008264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of tremor bursts by a running second order moment function and analysis using interburst histograms.
    Journée HL; Postma AA; Sun M; Staal MJ
    Med Eng Phys; 2008 Jan; 30(1):75-83. PubMed ID: 17280862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of medication on EMG patterns in individuals with Parkinson's disease.
    Robichaud JA; Pfann KD; Comella CL; Corcos DM
    Mov Disord; 2002 Sep; 17(5):950-60. PubMed ID: 12360544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tremor in Parkinson's disease: 24-hr monitoring with calibrated accelerometry.
    Thielgen T; Foerster F; Fuchs G; Hornig A; Fahrenberg J
    Electromyogr Clin Neurophysiol; 2004; 44(3):137-46. PubMed ID: 15125053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal evolution of oscillations and synchrony in GPi/muscle pairs in Parkinson's disease.
    Hurtado JM; Rubchinsky LL; Sigvardt KA; Wheelock VL; Pappas CT
    J Neurophysiol; 2005 Mar; 93(3):1569-84. PubMed ID: 15496492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
    Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
    Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine-responsive tremor in Parkinson's disease.
    Friedman JH; Lannon MC
    Mov Disord; 1990; 5(3):225-9. PubMed ID: 2388638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel computer-based technique for the assessment of tremor in Parkinson's disease.
    Aly NM; Playfer JR; Smith SL; Halliday DM
    Age Ageing; 2007 Jul; 36(4):395-9. PubMed ID: 17545208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.